Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications

BACKGROUND: Idiopathic Pulmonary Fibrosis is a chronic, progressive interstitial lung disease for which there is no cure. However, lung function decline, hospitalizations, and mortality may be reduced with the use of the antifibrotic medications, nintedanib and pirfenidone. Historical outcomes for h...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Pulm Med
Main Authors: Kelly, Bryan T., Thao, Viengneesee, Dempsey, Timothy M., Sangaralingham, Lindsey R., Payne, Stephanie R., Teague, Taylor T., Moua, Teng, Shah, Nilay D., Limper, Andrew H.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8286036/
https://ncbi.nlm.nih.gov/pubmed/34273943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-021-01607-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados